{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:11:10Z","timestamp":1793729470436,"version":"4.6.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007492","name":"Baylor University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.tox.2019.152339","type":"journal-article","created":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T11:55:22Z","timestamp":1575374122000},"page":"152339","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"special_numbering":"C","title":["Altered expression and activity of phase I and II biotransformation enzymes in human liver cells by perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS)"],"prefix":"10.1016","volume":"430","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9081-3966","authenticated-orcid":false,"given":"Marco E.","family":"Franco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace E.","family":"Sutherland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria T.","family":"Fernandez-Luna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2774-5104","authenticated-orcid":false,"given":"Ramon","family":"Lavado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tox.2019.152339_bib0005","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3390\/toxins9070212","article-title":"Metabolism of the marine phycotoxin PTX-2 and its effects on hepatic xenobiotic metabolism: activation of nuclear receptors and modulation of the phase I cytochrome P450","volume":"9","author":"Alarcan","year":"2017","journal-title":"Toxins"},{"key":"10.1016\/j.tox.2019.152339_bib0010","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1517\/17425255.2012.685159","article-title":"The HepaRG cell line: a unique in vitro tool for understanding drug metabolism and toxicology in human","volume":"8","author":"Andersson","year":"2012","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.tox.2019.152339_bib0015","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1124\/dmd.32.8.775","article-title":"The main role of UGT1A9 in the hepatic metabolism of mycophenolic acid and the effects of naturally occurring variants","volume":"32","author":"Bernard","year":"2004","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tox.2019.152339_bib0020","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1042\/bj2840417","article-title":"Multiplicity of UDP-glucuronosyltransferases in fish. Purification and characterization of a phenol UDP-glucuronosyltransferase from the liver of a marine teleost, Pleuronectes platessa","volume":"284","author":"Clarke","year":"1992","journal-title":"Biochem. J."},{"key":"10.1016\/j.tox.2019.152339_bib0025","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41370-018-0099-9","article-title":"Guideline levels for PFOA and PFOS in drinking water: the role of scientific uncertainty, risk assessment decisions, and social factors","volume":"29","author":"Cordner","year":"2019","journal-title":"J. Expo. Sci. Environ. Epidemiol."},{"key":"10.1016\/j.tox.2019.152339_bib0030","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s00244-008-9194-6","article-title":"Studies on the toxicological effects of PFOA and PFOS on rats using histological observation and chemical analysis","volume":"56","author":"Cui","year":"2009","journal-title":"Arch. Environ. Contam. Toxicol."},{"key":"10.1016\/j.tox.2019.152339_bib0035","series-title":"Toxicological Effects of Perfluoroalkyl and Polyfluoroalkyl Substances","author":"DeWitt","year":"2015"},{"key":"10.1016\/j.tox.2019.152339_bib0040","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.envres.2006.06.008","article-title":"Comparison of human whole blood, plasma, and serum matrices for the determination of perfluorooctanesulfonate (PFOS), perfluorooctanoate (PFOA), and other fluorochemicals","volume":"103","author":"Ehresman","year":"2007","journal-title":"Environ. Res."},{"key":"10.1016\/j.tox.2019.152339_bib0045","series-title":"Technical Fact Sheet - Perfluorooctane Sulfonate (PFOS) and Perfluorooctanoic Acid (PFOA). EPA 505-F-17-001, Office of Land and Emergency Management","author":"EPA","year":"2017"},{"key":"10.1016\/j.tox.2019.152339_bib0050","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.envint.2013.03.008","article-title":"Associations between PFOA, PFOS and changes in the expression of genes involved in cholesterol metabolism in humans","volume":"57-58","author":"Fletcher","year":"2013","journal-title":"Environ. Int."},{"key":"10.1016\/j.tox.2019.152339_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.aquatox.2019.05.016","article-title":"Prymnesium parvum differentially triggers sublethal fish antioxidant responses in vitro among salinity and nutrient conditions","volume":"213","author":"Franco","year":"2019","journal-title":"Aquat. Toxicol."},{"key":"10.1016\/j.tox.2019.152339_bib0060","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1289\/ehp.1104436","article-title":"Serum perfluorootanoate (PFOA) and perfluorooctane sulfonate (PFOS) concentrations and liver function biomarkers in a population with elevated PFOA exposure","volume":"120","author":"Gallo","year":"2012","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.tox.2019.152339_bib0065","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.chemosphere.2009.08.058","article-title":"PFOS and PFOA in environmental and tap water in China","volume":"77","author":"Jin","year":"2009","journal-title":"Chemosphere"},{"key":"10.1016\/j.tox.2019.152339_bib0070","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1124\/dmd.107.020016","article-title":"Evaluation of HepaRG cells as an in vitro model for human drug metabolism studies","volume":"36","author":"Kanebratt","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tox.2019.152339_bib0075","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1093\/toxsci\/kfm128","article-title":"Perfluoroalkyl acids: a review of monitoring and toxicological findings","volume":"99","author":"Lau","year":"2007","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2019.152339_bib0080","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.envpol.2005.05.003","article-title":"The combined use of chemical and biochemical markers to assess water quality along the Ebro River","volume":"139","author":"Lavado","year":"2006","journal-title":"Environ. Pollut."},{"key":"10.1016\/j.tox.2019.152339_bib0085","series-title":"The HepaRG Cell Line: Biological Properties and Relevance As a Tool for Cell Biology, Drug Metabolism, and Virology Studies. Hepatocytes","first-page":"261","author":"Marion","year":"2010"},{"key":"10.1016\/j.tox.2019.152339_bib0090","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1124\/jpet.300.2.361","article-title":"The ontogeny of human drug-metabolizing enzymes: phase II conjugation enzymes and regulatory mechanisms","volume":"300","author":"McCarver","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2019.152339_bib0095","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1039\/b307147m","article-title":"Concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) in vacuum cleaner dust collected in Japanese homes","volume":"5","author":"Moriwaki","year":"2003","journal-title":"J. Environ. Monit."},{"key":"10.1016\/j.tox.2019.152339_bib0100","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.cbi.2011.09.002","article-title":"Characterization of inhibitory effects of perfluorooctane sulfonate on human hepatic cytochrome P450 isoenzymes: focusing on CYP2A6","volume":"194","author":"Narimatsu","year":"2011","journal-title":"Chem-Biol. Interact."},{"key":"10.1016\/j.tox.2019.152339_bib0105","doi-asserted-by":"crossref","first-page":"7496","DOI":"10.1021\/jf104943p","article-title":"Levels of perfluorinated compounds in food and dietary intake of PFOS and PFOA in the Netherlands","volume":"59","author":"Noorlander","year":"2011","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.tox.2019.152339_bib0110","series-title":"Evaluation of the Half-life (t1\/2) of Elimination of Perfluorooctanesulfonate (PFOS), Perfluorohecanefulfonate (PFHS) and Perfluorooctanoate (PFOA) From Human Serum, 2005a Abstract TOXC017. FLUOROS 2005, 18-20 August 2005","author":"Olsen","year":"2005"},{"key":"10.1016\/j.tox.2019.152339_bib0115","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1242\/dev.132209","article-title":"Asialoglycoprotein receptor 1 is a specific cell-surface marker for isolating hepatocytes derived from human pluripotent stem cells","volume":"143","author":"Peters","year":"2016","journal-title":"Development"},{"key":"10.1016\/j.tox.2019.152339_bib0120","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3109\/03602539709037591","article-title":"Human cytochrime P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors","volume":"29","author":"Rendic","year":"1997","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.tox.2019.152339_bib0125","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1161\/ATVBAHA.107.158998","article-title":"Regulation of macrophage functions by PPAR-alpha, PPAR-gamma, and LXRs in mice and men","volume":"28","author":"Rigamonti","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.tox.2019.152339_bib0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/toxsci\/kfp142","article-title":"Does exposure to perfluoroalkyl acids present a risk to human health?","volume":"111","author":"Rosen","year":"2009","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2019.152339_bib0135","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/j.chemosphere.2013.07.054","article-title":"Enhanced cytotoxicity of pentachlorophenol by perfluorooctane sulfonate or perfluorooctanoic acid in HepG2 cells","volume":"93","author":"Shan","year":"2013","journal-title":"Chemosphere"},{"key":"10.1016\/j.tox.2019.152339_bib0140","doi-asserted-by":"crossref","first-page":"942","DOI":"10.3724\/SP.J.1123.2014.05028","article-title":"Analysis of perfluorooctanoic acid by high performance liquid chromatography with 3,4-dichloroaniline derivatization","volume":"32","author":"Shan","year":"2014","journal-title":"Chin. J. Chromatogr."},{"key":"10.1016\/j.tox.2019.152339_bib0145","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2337\/diab.42.5.773","article-title":"Organization of the human GLUT2 (pancreatic \u03b2-cell and hepatocyte) glucose transporter gene","volume":"42","author":"Takeda","year":"1993","journal-title":"Diabetes"},{"key":"10.1016\/j.tox.2019.152339_bib0150","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3390\/cells8020192","article-title":"In-depth proteome analysis highlights HepaRG cells as a versatile cell system surrogate for primary human hepatocytes","volume":"8","author":"Tascher","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.tox.2019.152339_bib0155","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1539-6924.2008.01017.x","article-title":"Estimating consumer exposure to PFOS and PFOA","volume":"28","author":"Trudel","year":"2008","journal-title":"Risk Anal."},{"key":"10.1016\/j.tox.2019.152339_bib0160","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3109\/03602530903286476","article-title":"Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2","volume":"42","author":"Zhou","year":"2010","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.tox.2019.152339_bib0165","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nature13020","article-title":"Mouse liver repopulation with hepatocytes generated from human fibroblasts","volume":"508","author":"Zhu","year":"2014","journal-title":"Nature"}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X19302963?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X19302963?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T23:41:51Z","timestamp":1759534911000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X19302963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":33,"alternative-id":["S0300483X19302963"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2019.152339","relation":{},"ISSN":["0300-483X"],"issn-type":[{"value":"0300-483X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered expression and activity of phase I and II biotransformation enzymes in human liver cells by perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS)","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2019.152339","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152339"}}